lisocabtagene maraleucel

Italy

Drugs containing this active substance

  • BREYANZI

    Breyanzi is used for the treatment of adults with certain types of blood cancer (lymphoma) that affect the lymphatic tissues, including diffuse large B-cell lymphoma, high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.

    Form: solution for infusion

    Active substance Dosage
    lisocabtagene maraleucel -

    ATC: L01

    Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG